LPL is an enzyme which catabolizes Triglyceride (TG) in triglyceride-rich lipoproteins such as dietary-derived Chylomicron and VLDL synthesized in the liver and it has an important role for TG metabolism with as the essential factor ApoC-II.<br><br>
LPL is bound by GPIHBP1 or heparan sulfate proteoglycan on the surface of microvascular endothelium of adipose tissue rather than the liver or muscles. Deficient of LPL and declining of its function are found in type I, IV and V hyperlipemia and it has been considered that they are one of the cause of high TG. This kit can quantitatively measure LPL in mouse serum and mouse post heparin EDTA-plasma.<br><br>
Control set 27603-QC is available for purchase.
- Assay Description:
- Overnight incubation (4°C) + 30 min. (4°C) + 30 min. (RT) = Overnight + 1 hour total incubation time
- Catalog number:
- 27603
- configuration:
- 96 Determinations, 12x8 removable strips
- Protocol:
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- design:
- Solid phase sandwich ELISA technique
- MSDS:
- Please Inquire
- FDA Status:
- For research use only, not for use in diagnostic procedures
- controls:
- 27603-QC
- Sample types:
- Mouse serum, EDTA plasma and Post heparin plasma
- Sample volume:
- 100 µL prepared test sample
- standards:
- 7 standards
- Standard range:
- 0 / 0.31 - 20 ng/mL
- storage:
- 2 - 8 °C
- sensitivity:
- 0.036 ng/mL
- Species:
- Mouse
